MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Hu Z, Klein JD, Mitch WE, Zhang L, Martinez I, Wang XH. Aging (Albany.NY). 2014;6(3):160-175 PMC4012934.

Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) induction in human peripheral blood mononuclear cells.Unlu S, Tang S, Wang E, Martinez I, Tang D, Bianchi ME, Zeh HJ, Lotze MT.  PLoS One.2012;7(6):e38899 PMC3382181.

B-Myb, cancer, senescence, and microRNAs. Martinez I, DiMaio D. Cancer Res. 2011;71(16):5370-5373 PMC3156249.

miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. Proc Natl Acad Sci USA. 2011;108(2):522-527. PMC3021067.

MicroRNAs and senescence. Martinez I, Almstead LL, DiMaio D. Aging (Albany.NY). 2011;3(2):77-78. PMC3082014.

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA.
Oncogene. 2008;27(18):2575-2582

Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. Eur J Cancer. 2007;43(2):415-432 PMC1847595.

Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Ferris RL, Martinez I, Sirianni N, Wang J, Lopez-Albaitero A, Gollin SM, Johnson JT, Khan S. Eur J Cancer. 2005;41(5):807-815.

High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas. Martinez I, Mantilla A, Medrano ME, Hernandez R, Hernandez DM, Lazos M, Santiago H, Gonzalez B, Hidalgo A, Salcedo M. Endocr Pathol. 2001;12(2):113-123.

Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B. Hidalgo A, Medrano ME, Rodriguez S, Franco C, Martinez I, Benitez L, Salcedo M. J Exp Clin Cancer Res. 1998;17(2):149-152.